Skip to main content
. 2023 Mar 8;21(3):727–739. doi: 10.2174/1570159X20666220411092813

Table 1.

Patient demographic characteristics and comorbidities, stratified by antidepressant.

- - OVERALL Antidepressant Molecule
Citalopram Duloxetine Escitalopram Paroxetine Sertraline Venlafaxine Vortioxetine
- N (%) 8235 - 1062 - 565 - 1939 - 1882 - 1737 - 606 - 444 -
Gender - - - - - - - - - - - - - - - - -
Female n (%) 5535 67.2 744 70.1 389 68.9 1324 68.3 1285 68.3 1122 64.6 395 65.2 276 62.2
Agea - - - - - - - - - - - - - - - - -
≤40 years old n (%) 994 12.1 103 9.7 46 8.1 254 13.1 234 12.4 204 11.7 85 14.0 68 15.3
41-64 years old n (%) 3279 39.8 391 36.8 249 44.1 798 41.2 810 43.0 588 33.9 269 44.4 174 39.2
≥65 years old n (%) 3962 48.1 568 53.5 270 47.8 887 45.8 838 44.5 945 54.4 252 41.6 202 45.5
Comorbiditiesb - - - - - - - - - - - - - - - - -
Hypertension n (%) 3838 45.5 521 44.9 274 43.6 894 47.2 796 46.5 872 44.7 273 44.8 208 43.6
Hyperlipidemia n (%) 1804 21.4 241 20.8 144 22.9 400 21.1 409 23.9 391 20.1 122 20.0 97 20.3
Diabetes n (%) 1145 13.6 158 13.6 92 14.6 242 12.8 225 13.1 274 14.1 89 14.6 65 13.6
Cerebrovascular Disease n (%) 969 11.5 141 12.2 77 12.2 193 10.2 169 9.9 240 12.3 76 12.5 73 15.3
Coronary Artery Disease n (%) 674 8.0 99 8.5 42 6.7 164 8.7 113 6.6 172 8.8 50 8.2 34 7.1
Anxiety n (%) 876 9.1 117 9.4 60 9.0 200 8.9 228 10.2 180 8.9 55 7.7 36 6.9
Previous history of AD treatment - - - - - - - - - - - - - - - - -
Unknownc n (%) 1212 14.7 148 13.9 72 12.7 288 14.9 279 14.8 247 14.2 97 16.0 81 18.2
Naive n (%) 3209 39.0 405 38.1 215 38.1 771 39.8 717 38.1 714 41.1 205 33.8 182 41.0
Non-naive n (%) 3814 46.3 509 47.9 278 49.2 880 45.4 886 47.1 776 44.7 304 50.2 181 40.8

a age calculated at index date; b comorbidities 1- year pre index date; c patients without 10 years of available data in IQVIA LPD.